Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-18,157
Closed -$185K 302
2025
Q2
$185K Hold
18,157
﹤0.01% 1090
2025
Q1
$143K Buy
+18,157
New +$223K ﹤0.01% 1033
2024
Q1
Sell
-15,011
Closed -$295K 1078
2023
Q4
$295K Sell
15,011
-22,289
-60% -$387K ﹤0.01% 997
2023
Q3
$760K Buy
+37,300
New +$938K ﹤0.01% 876
2023
Q2
Sell
-82,700
Closed -$2.32M 1100
2023
Q1
$2.32M Sell
82,700
-115,000
-58% -$2.95M 0.01% 737
2022
Q4
$3.66M Hold
197,700
0.01% 670
2022
Q3
$3.11M Buy
197,700
+3,300
+2% +$74.1K 0.01% 676
2022
Q2
$4.9M Buy
194,400
+71,000
+58% +$2.12M 0.02% 587
2022
Q1
$4.45M Buy
123,400
+42,101
+52% +$2.07M 0.01% 672
2021
Q4
$6.23M Sell
81,299
-22,600
-22% -$1.99M 0.02% 609
2021
Q3
$9.99M Sell
103,899
-3,300
-3% -$360K 0.03% 498
2021
Q2
$11.4M Sell
107,199
-22,090
-17% -$2.17M 0.03% 484
2021
Q1
$11.6M Sell
129,289
-52,417
-29% -$5.77M 0.04% 485
2020
Q4
$18.3M Sell
181,706
-12,794
-7% -$954K 0.06% 351
2020
Q3
$9.51M Buy
194,500
+110,400
+131% +$5.3M 0.03% 471
2020
Q2
$3.44M Buy
+84,100
New +$2.42M 0.01% 710

Other funds holding CRNC

Axa's CRNC Position: Q3 2025 in Review

Axa sold out of Cerence (CRNC) in Q3 2025, closing a stake of 18,157 shares — an estimated $185K sold.

Axa first reported a position in CRNC in Q2 2020 and held it in 16 quarters. The position peaked at $18.3M in Q4 2020. 189 funds tracked by Wall St. Rank hold CRNC as of Q3 2025.

  • Axa reported no remaining Cerence position as of Q3 2025 after selling out during the quarter.
  • Axa sold 18,157 Cerence shares in Q3 2025, an estimated $185K.
  • Axa first reported a position in Cerence in Q2 2020 and held it in 16 quarters.
  • Axa's Cerence position peaked at $18.3M in Q4 2020.
  • 189 funds tracked by Wall St. Rank held Cerence as of Q3 2025.

Based on Axa's 13F filing for Q3 2025, filed 14 Nov 2025.